These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2690898)

  • 1. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Mosekilde L; Melsen F
    Bone; 1989; 10(5):313-20. PubMed ID: 2690898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime.
    Steiniche T; Hasling C; Charles P; Eriksen EF; Melsen F; Mosekilde L
    Bone; 1991; 12(3):155-63. PubMed ID: 1910957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C; Riis BJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):836-41. PubMed ID: 2205624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF; Christiansen C; Transbøl I
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C; AgnusDei D; Gonnelli S; Nardi P
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF; Meinecke B; Boesen J; Transbøl I
    Clin Orthop Relat Res; 1985; (192):215-21. PubMed ID: 3881203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study.
    Alexandersen P; Riis BJ; Christiansen C
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3013-20. PubMed ID: 10487657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.
    Morabito N; Crisafulli A; Vergara C; Gaudio A; Lasco A; Frisina N; D'Anna R; Corrado F; Pizzoleo MA; Cincotta M; Altavilla D; Ientile R; Squadrito F
    J Bone Miner Res; 2002 Oct; 17(10):1904-12. PubMed ID: 12369794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effects of oestrogen/progestogen, high-dose oral calcium, intermittent cyclic etidronate and an ADFR regime on calcium kinetics and bone mass in postmenopausal women with spinal osteoporosis.
    Hasling C; Charles P; Jensen FT; Mosekilde L
    Osteoporos Int; 1994 Jul; 4(4):191-203. PubMed ID: 7949749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects.
    Greenwald MW; Gluck OS; Lang E; Rakov V
    Menopause; 2005; 12(6):741-8. PubMed ID: 16278618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
    Resch H; Pietschmann P; Willvonseder R
    Calcif Tissue Int; 1989 Oct; 45(4):209-13. PubMed ID: 2509007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of one-year hormone replacement therapy on peripheral bone mineral content in patients with osteoporotic spine fractures.
    Resch H; Pietschmann P; Krexner E; Woloszczuk W; Willvonseder R
    Acta Endocrinol (Copenh); 1990 Jul; 123(1):14-8. PubMed ID: 2389624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of postmenopausal osteoporosis with transdermal estrogen.
    Lufkin EG; Wahner HW; O'Fallon WM; Hodgson SF; Kotowicz MA; Lane AW; Judd HL; Caplan RH; Riggs BL
    Ann Intern Med; 1992 Jul; 117(1):1-9. PubMed ID: 1534476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J; Christiansen C; Catherwood BD; Deftos LJ
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary hyperparathyroidism: bone structure, balance, and remodeling before and 3 years after surgical treatment.
    Steiniche T; Christiansen P; Vesterby A; Ullerup R; Hessov I; Mosekilde LE; Melsen F
    Bone; 2000 May; 26(5):535-43. PubMed ID: 10773596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
    Johansen JS; Jensen SB; Riis BJ; Christiansen C
    Metabolism; 1990 Nov; 39(11):1122-6. PubMed ID: 2233271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
    Stevenson JC; Cust MP; Gangar KF; Hillard TC; Lees B; Whitehead MI
    Lancet; 1990 Aug; 336(8710):265-9. PubMed ID: 1973969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C; Rødbro P; Tjellesen L
    Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
    JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.